OH SB269

Enacts section 4729.521 of Ohio Revised Code to prohibit drug manufacturers, wholesalers, repackagers, and third-party logistics providers from denying, restricting, or discriminating against acquisition or delivery of 340B drugs to covered entities, unless prohibited by federal law.

Prohibits requiring 340B covered entities to submit claims or utilization data as a condition for drug acquisition or delivery, unless required by the United States Department of Health and Human Services.

Establishes violations as unlawful practices under section 1345.02 of the Revised Code, with the Attorney General authorized to assess civil penalties of $50,000 per violation, with each package of 340B drugs constituting a separate violation.

Allows the Attorney General to refer complaints to the State Board of Pharmacy for consideration of sanctions under section 4729.56 of the Revised Code.

Authorizes the Attorney General or Board of Pharmacy to adopt rules under Chapter 119 of the Revised Code to implement the section, while ensuring the law does not conflict with applicable federal law or regulations.